Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Primary objective:
To find out an optimal regimen of OHA (oral hypoglycaemic agents) in combination with insulin
glargine (metformin, glimepiride or metformin+glimepiride) by measuring HbA1c level
Secondary objective:
To compare the incidence of hypoglycemia in each treatment group